Sign in

CIK 0000811641

  • Non-accelerated filer
  • Smaller reporting company

IMMUCELL CORP /DE/

Sign in to watch
Ticker
ICCC
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010382980
Phone
+1 207-878-2770
Business address
56 EVERGREEN DR, PORTLAND, ME, 04103
  1. 4 Open-market buy Director bought 3,000 shares at an average $3.70 ($11,106)
  2. 4 Open-market buy Director bought 5,483 shares at an average $3.82 ($20,960)
  3. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  4. 4 Open-market buy Director bought 2,777 shares at an average $5.91 ($16,417)
  5. 4 Open-market buy Director bought 1,696 shares at an average $5.56 ($9,430)
  6. 4 Open-market buy Director bought 4,450 shares at an average $5.75 ($25,590)
  7. 4 Open-market buy Director bought 2,357 shares at an average $5.39 ($12,701)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  13. 4 Open-market sale Director sold 12,500 shares at an average $6.75 ($84,392)
  14. 4 Open-market sale Director sold 2,500 shares at $6.90 ($17,241)
  15. 4 Exercise or conversion Vice President & CSO acquired 12,000 shares (option exercise)
  16. 4 Exercise or conversion President & CEO acquired 12,000 shares (option exercise)
  17. 4 Exercise or conversion President & CEO acquired 500 shares (option exercise)
  18. 4 Exercise or conversion Vice President & CSO acquired 500 shares (option exercise)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)

Page 11 of 13 · 256 filings